Actively Recruiting
Artificial Intelligence in Colonoscopy
Led by Jagiellonian University · Updated on 2025-01-22
630
Participants Needed
2
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Colorectal cancer is the second most common malignancy in the countries of the European Union. Colonoscopy is the primary method for detecting and preventing the development of colorectal cancer is endoscopic examination. This study aims to evaluate the impact of artificial intelligence on the detection rate of polyps and early stages of colorectal cancer.
CONDITIONS
Official Title
Artificial Intelligence in Colonoscopy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Consent to participate in the study
- Age between 50 and 65 years
- Scheduled outpatient colonoscopy
You will not qualify if you...
- Previous colonoscopy
- History of colorectal surgery
- Ongoing biological therapy for any indication
- Primary sclerosing cholangitis
- Familial polyposis syndrome
- Chronic diarrhea
- Ulcerative colitis
- Crohn's disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
MEDICINA Medical Center
Krakow, Lesser Poladn, Poland, 31559
Actively Recruiting
2
Brothers Hospitallers Medical Center, Hospital of St John of god in Krakow
Krakow, Lesser Polasd, Poland, 31061
Actively Recruiting
Research Team
Z
Zofia Orzeszko, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here